New Zealand Anti-Smoking Website Criticized for Misrepresenting E-Cigarettes

Aug.10.2022
New Zealand Anti-Smoking Website Criticized for Misrepresenting E-Cigarettes
The "Don't Smoke" anti-e-cigarette website lacks scientific facts and may send false messages about e-cigarettes.

The "Quit Vaping" website was established by the Asthma and Respiratory Foundation of New Zealand (ARFNZ), but unfortunately, it fails to provide all scientific facts related to electronic cigarettes. In a recent press release, the Coalition of Asia Pacific Tobacco Harm Reduction Advocates (CAPHRA) revealed that it had examined the website and sadly found that "while the website focuses on the science, it fails to provide a comprehensive picture of electronic cigarettes.


The homepage of the anti-electronic cigarette website reads "Do not smoke.


To make matters worse, the website has continued to make false claims about the safety of electronic cigarettes, potentially spreading misinformation to the public and preventing smokers from switching to safer alternatives.


Loucas emphasized that New Zealand's tobacco harm reduction strategy is actually working, but unfortunately, ARANZ's actions go against this progress. "New Zealand has implemented an effective tobacco harm reduction (THR) strategy, and the country's overall smoking rates are at their lowest levels in history. With the government refocusing on the Smokefree Aotearoa 2025 plan, it's unfortunate that ARFNZ is working hard to prevent the remaining smokers from transitioning to safer alternatives," she said.


Lucas mentioned claims about hazardous chemicals found in vapor. These misleading statements include the notion that nicotine harms the brains of adolescents, children, and fetuses. Additionally, e-cigarette vapor may potentially contain harmful substances such as formaldehyde, carcinogenic chemicals, and heavy metals. Children and adults could become poisoned by ingesting e-liquid or absorbing it through their skin or eyes. Furthermore, e-cigarettes have been linked to thousands of cases of severe lung damage.


If any of these claims are combined, do you think the New Zealand Ministry of Health would actively encourage smokers, including pregnant women, to switch to e-cigarettes as an effective smoking cessation tool?


These claims have been debunked by science.


She added that countless scientific studies reviewed by peers and recognition from globally renowned health organizations, such as the NHS, completely refute these claims.


Compared to the deadly effects of smoking, the website for electronic cigarettes provides some appropriate background information. However, it does not mention that no New Zealanders have reportedly died from using electronic cigarettes, nor does it acknowledge the English Public Health Department's firm stance that the hazards of vaping are 95% lower than those of smoking combustible cigarettes.


Let us fight with facts instead of fueling emotions. ARFNZ is creating an non-existent hysteria. They claim to be running an education campaign, but it is merely political persecution," she concluded.


Statement:


This article is compiled based on third-party information and is intended for industry communication and learning purposes.


This article does not represent the viewpoint of 2FIRSTS, and 2FIRSTS cannot confirm the authenticity or accuracy of the article's content. The translation of this article is solely for exchange and research within the industry.


Due to limitations in the translator's proficiency, the translated article may not fully reflect the original expression. Please refer to the original text for accuracy.


2FIRSTS maintains complete alignment with the Chinese government on any domestic, Hong Kong, Macau, Taiwan, or foreign-related statements and positions.


Copyright of compiled information belongs to the original media and author. If there is any infringement, please contact us for deletion.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Canadian Court Allows Juul and Altria Vape Class Action to Move Forward Over Youth Marketing Claims
Canadian Court Allows Juul and Altria Vape Class Action to Move Forward Over Youth Marketing Claims
A Quebec Superior Court has allowed a class action lawsuit against Juul Labs and Altria Group related to vaping products to proceed, involving allegations concerning marketing practices, youth exposure and corporate responsibility. The ruling only allows the case to move forward and does not represent a finding that Juul or Altria are legally liable. The case highlights continued legal risks facing vape companies regarding product marketing, youth protection and corporate accountability.
Jul.28
Malaysia Police Plan Saliva Tests at Roadblocks to Detect Synthetic Drugs Mixed Into Vape Liquids
Malaysia Police Plan Saliva Tests at Roadblocks to Detect Synthetic Drugs Mixed Into Vape Liquids
Malaysian police plan to use saliva test kits at roadblocks to detect drivers using synthetic liquid drugs marketed as “Piu Piu” and “Magic Mushroom,” substances that authorities say are mixed into vape liquids and inhaled through e-cigarette devices, raising road-safety concerns and adding pressure on vape regulation.
Jun.29
Vietnam’s Vape Crackdown Expands From Ban Proposal to Grassroots Enforcement
Vietnam’s Vape Crackdown Expands From Ban Proposal to Grassroots Enforcement
Vietnam tightens e-cigarette rules. Health Ministry proposes banning production, trade, transport, storage, ads, promotion, sponsorship, and use of e-cigarettes, heated tobacco, and new products. Hanoi also urges residents to report illegal activities, showing enforcement moves from lawmaking to local action.
Jul.08
 $20 Million, a Permanent Injunction and Distributor Controls: Posh Deal Tightens Illinois Vape Compliance
$20 Million, a Permanent Injunction and Distributor Controls: Posh Deal Tightens Illinois Vape Compliance
An Illinois court ordered three companies tied to Posh vapes to pay $20 million and permanently restricted the sale, marketing and distribution in Illinois of products lacking required FDA authorization. The consent order also imposes downstream distributor controls, age-verification measures and social-media marketing limits, creating a new state-level compliance benchmark for disposable vape businesses.
Regulations
Aug.05
2Firsts Data | China’s Vape Exports Rise 3.1% in H1 2026 as 6-Methyl Nicotine-Related Products Surge 65.2%
2Firsts Data | China’s Vape Exports Rise 3.1% in H1 2026 as 6-Methyl Nicotine-Related Products Surge 65.2%
China’s vape exports showed resilience in the first half of 2026 after a short-term shock from China’s export rebate adjustment. But customs data points to more than a simple recovery: the structure of growth is changing. Vaping devices and atomization hardware emerged as the strongest growth driver, while nicotine-containing vaping products remained broadly stable. Meanwhile, nicotine substitute-related products represented by 6-methyl nicotine expanded rapidly, becoming a new category to watch for both industry and regulators. After the U.S. market went through a cycle of shortages, replenishment and inventory rebuilding in 2025, China’s vape supply chain is entering a new phase of reallocation.
Special Report
Jul.20
South Korea Rejects 16 Trillion Won Tax-Evasion Claim Over Chinese Synthetic Nicotine
South Korea Rejects 16 Trillion Won Tax-Evasion Claim Over Chinese Synthetic Nicotine
The South Korean government rejected allegations that Chinese synthetic-nicotine e-liquids were linked to about 16 trillion won in tobacco tax evasion, saying China does not ban synthetic nicotine exports and the estimate is difficult to verify, while acknowledging that pre-law synthetic-nicotine inventory is effectively difficult to tax.
Market
Jun.25